Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H16N2.ClH |
| Molecular Weight | 224.73 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN(C)CCC1=CNC2=CC=CC=C12
InChI
InChIKey=FXCHKLOHTIIVJW-UHFFFAOYSA-N
InChI=1S/C12H16N2.ClH/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12;/h3-6,9,13H,7-8H2,1-2H3;1H
| Molecular Formula | C12H16N2 |
| Molecular Weight | 188.2688 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A proposed mechanism for the visions of dream sleep. | 1988 Jun |
|
| Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. | 1994 Feb |
|
| [Antimycobacterial indole derivatives]. | 1994 Feb |
|
| Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. | 1996 Dec |
|
| 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens. | 2002 May |
|
| Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. | 2004 May |
|
| Various alkaloid profiles in decoctions of Banisteriopsis caapi. | 2005 Jun |
|
| Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. | 2005 Jun |
|
| Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. | 2006 May |
|
| NMR spectral assignments of a new chlorotryptamine alkaloid and its analogues from Acacia confusa. | 2007 Apr |
|
| DMT at fifty. | 2007 Dec |
|
| Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors. | 2007 Mar 15 |
|
| The globalization of ayahuasca: harm reduction or benefit maximization? | 2008 Aug |
|
| Secondary metabolites from three Florida sponges with antidepressant activity. | 2008 Feb |
|
| A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. | 2008 Jan 15 |
|
| Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. | 2008 Jul |
|
| Halogenated solvent interactions with N,N-dimethyltryptamine: formation of quaternary ammonium salts and their artificially induced rearrangements during analysis. | 2008 Jul 4 |
|
| The "vine of the soul" vs. the Controlled Substances Act: implications of the hoasca case. | 2008 Jun |
|
| [Inhibition of return in schizophrenia: a review]. | 2008 Jun |
|
| [Hallucinogen-induced psychological disorders]. | 2008 Jun |
|
| Indolealkylamines: biotransformations and potential drug-drug interactions. | 2008 Jun |
|
| Ayahuasca versus violence--a case report. | 2008 May |
|
| Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis. | 2008 Nov |
|
| Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. | 2008 Nov |
|
| Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage. | 2008 Oct |
|
| Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases. | 2009 |
|
| Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. | 2009 Jul |
|
| Analysis of toxic alkaloids in body samples. | 2009 Mar 10 |
|
| Predicting new molecular targets for known drugs. | 2009 Nov 12 |
|
| Psychometric evaluation of the altered states of consciousness rating scale (OAV). | 2010 Aug 31 |
|
| Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry. | 2010 Jul |
|
| Alkaloids from Fissistigma latifolium (Dunal) Merr. | 2010 Jun 24 |
|
| Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management. | 2010 Jun 24 |
|
| The hallucinogenic world of tryptamines: an updated review. | 2015 Aug |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:21:24 GMT 2023
by
admin
on
Fri Dec 15 15:21:24 GMT 2023
|
| Record UNII |
PRC2H3HFU4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
PRC2H3HFU4
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
2826-93-9
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
PD 004
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
25944
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|